Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-01-22 @ 12:58 PM
Study NCT ID:
NCT06972732
Status:
RECRUITING
Last Update Posted:
2025-09-15
First Post:
2025-05-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Sponsor:
Boryung Pharmaceutical Co., Ltd
Organization: